Robert Toussaint Poirier

Title: The Innovations of Robert Toussaint Poirier

Introduction

Robert Toussaint Poirier is an accomplished inventor based in Medicine Hat, Canada. He has made significant contributions to the field of immunology through his innovative research and patent developments. His work focuses on serum components that interact with threat agents, showcasing his expertise in the area of vaccine development.

Latest Patents

Poirier holds a patent for "Serum components that bind to threat agents." This invention involves low molecular weight serum components, which are less than 10,000 m.w., that bind to purified O-polysaccharide (OPS) in vaccinated animals and humans exposed to threat agents. The patent describes how these components form a loose reversible precipitin with OPS in a high-salt borate-buffered agarose gel. Additionally, it reveals the binding of these components to candidate vaccines, as observed through capillary electrophoresis. The invention also identifies two larger serum components that resemble serum albumin and mannan-binding lectin, which bind to the vaccine. An indirect method for identifying vaccination is also disclosed, based on the presence of antibodies against OPS. Various studies, including ELISA and animal challenge studies, indicated that up to 30% of control animals did not require vaccination, suggesting natural exposure to cross-reactive antigens.

Career Highlights

Poirier is associated with Her Majesty the Queen in Right of Canada, as represented by the Minister of National Defence. His work in this capacity has allowed him to contribute to important research initiatives that enhance national defense through innovative medical solutions.

Collaborations

Poirier has collaborated with notable colleagues, including William Edward Lee and John Walter Cherwonogrodzky. These partnerships have fostered a collaborative environment that promotes the advancement of research and innovation in their field.

Conclusion

Robert Toussaint Poirier's contributions to the field of immunology through his patent and collaborative efforts highlight his role as a significant inventor. His work continues to influence vaccine development and the understanding of serum components in relation to threat agents.